In a blunt public intervention that could have far-reaching consequences, including in Australia and New Zealand, the US Ambassador to the UK has warned that pharmaceutical companies may halt further investments or even shut down operations in the country unless it increases the prices it pays for medicines.
US Ambassador warns UK risks losing pharma investment unless it pays more for medicines
November 6, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Donald Trump announces 'MFN' deals with Lilly and Novo Nordisk and end to 'global freeloading'
November 7, 2025 - - Latest News -
Sanofi employees contribute over 400 volunteer hours to community and environmental causes
November 6, 2025 - - Latest News -
Neuren posts record royalties as DAYBUE sales surpass US$100 million in third quarter
November 6, 2025 - - Australian Biotech -
US Ambassador warns UK risks losing pharma investment unless it pays more for medicines
November 6, 2025 - - Latest News -
Pfizer to continue legal fight as court rejects bid to block Novo Nordisk’s Metsera takeover bid
November 6, 2025 - - Latest News -
What next for PBS rebate system amid constitutional breaches, disputed claims, and global pressure?
November 6, 2025 - - Latest News -
Linda Burney to chair new First Nations Pharmacy Network
November 5, 2025 - - Latest News
